Literature DB >> 17962488

Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population.

Keisuke Mori1, Peter L Gehlbach, Sho Kabasawa, Izumi Kawasaki, Masataka Oosaki, Hiroyuki Iizuka, Shigehiro Katayama, Takuya Awata, Shin Yoneya.   

Abstract

PURPOSE: Ethnic variation has been reported in age-related macular degeneration (AMD)-associated Y402H polymorphism in complement factor H (CFH). This variation is evident in the Japanese population. Recently a strong association between a novel single-nucleotide polymorphism (SNP; rs1410996) in the CFH gene and AMD has been identified in Caucasian patients. The present study was undertaken to investigate whether four coding and noncoding variants of the CFH gene, including rs1410996, are associated with AMD in native, unrelated Japanese patients.
METHODS: A total of 188 patients with AMD and 139 control subjects without AMD were recruited for the study. Four SNPs (rs800292, rs1061170, rs1410996, and rs2274700) in the CFH gene were assessed by genotyping assay. The information regarding systemic conditions and lifestyle including smoking were documented in each subject by standardized questionnaire.
RESULTS: The intronic SNP (rs1410996) and the synonymous SNP (rs2274700) were associated with a significant risk of AMD (P = 2.37 x 10(-5) and 3.52 x 10(-5), respectively). A significant association was also noted between a coding variant (rs800292, I62V) and AMD (P = 8.63 x 10(-6)). In contrast, the Y402H variant showed no significant association with AMD (P = 0.101). Two common haplotypes also demonstrated significant association with AMD (P = 1.08 x 10(-3) and 2.00 x 10(-5)). Among the environmental factors, smoking alone had a significant association with AMD (P = 1.17 x 10(-4)).
CONCLUSIONS: Although the Y402H variant was not significantly associated with AMD, other coding and noncoding variants in the CFH gene including rs1410996 and smoking moderately influenced the risk of AMD in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962488     DOI: 10.1167/iovs.07-0426

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

Review 1.  Validating, augmenting and refining genome-wide association signals.

Authors:  John P A Ioannidis; Gilles Thomas; Mark J Daly
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 2.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

3.  Nerve fiber layer thickness in exudative age-related macular degeneration in Japanese patients.

Authors:  Kentaro Yuda; Yuji Inoue; Atsuo Tomidokoro; Yasuhiro Tamaki; Yasuo Yanagi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-31       Impact factor: 3.117

4.  Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population.

Authors:  L Huang; Q Meng; C Zhang; Y Sun; Y Bai; S Li; X Deng; B Wang; W Yu; M Zhao; X Li
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

5.  VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration.

Authors:  Isao Nakata; Kenji Yamashiro; Hideo Nakanishi; Akitaka Tsujikawa; Atsushi Otani; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2011-07-09       Impact factor: 2.447

6.  Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy.

Authors:  Norimoto Gotoh; Kenji Yamashiro; Hideo Nakanishi; Masaaki Saito; Tomohiro Iida; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

7.  Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population.

Authors:  Asako Goto; Masakazu Akahori; Haru Okamoto; Masayoshi Minami; Naoki Terauchi; Yuji Haruhata; Minoru Obazawa; Toru Noda; Miki Honda; Atsushi Mizota; Minoru Tanaka; Takaaki Hayashi; Masaki Tanito; Naoko Ogata; Takeshi Iwata
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-22

8.  Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.

Authors:  Johanna M Seddon; Robyn Reynolds; Bernard Rosner
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

9.  Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.

Authors:  Reecha Sofat; Juan P Casas; Andrew R Webster; Alan C Bird; Samantha S Mann; John R W Yates; Anthony T Moore; Tiina Sepp; Valentina Cipriani; Catey Bunce; Jane C Khan; Humma Shahid; Anand Swaroop; Gonçalo Abecasis; Kari E H Branham; Sepideh Zareparsi; Arthur A Bergen; Caroline C W Klaver; Dominique C Baas; Kang Zhang; Yuhong Chen; Daniel Gibbs; Bernhard H F Weber; Claudia N Keilhauer; Lars G Fritsche; Andrew Lotery; Angela J Cree; Helen L Griffiths; Shomi S Bhattacharya; Li L Chen; Sharon A Jenkins; Tunde Peto; Mark Lathrop; Thierry Leveillard; Michael B Gorin; Daniel E Weeks; Maria Carolina Ortube; Robert E Ferrell; Johanna Jakobsdottir; Yvette P Conley; Mati Rahu; Johan H Seland; Gisele Soubrane; Fotis Topouzis; Jesus Vioque; Laura Tomazzoli; Ian Young; John Whittaker; Usha Chakravarthy; Paulus T V M de Jong; Liam Smeeth; Astrid Fletcher; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2012-01-13       Impact factor: 7.196

10.  An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism.

Authors:  Bareng A S Nonyane; Dorothea Nitsch; John C Whittaker; Reecha Sofat; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.